Intranasal butyl patients perennial rhinitis efficacy safety study nasal biopsy Fluocortin butyl FCB topical intranasal corticosteroid powder symptoms signs perennial rhinitis previous short-term studies multicenter open-label study efficacy safety FCB treatment period patients perennial rhinitis Treatment inhalation FCB nostril times day total dosage mg/day subsequent months third patients dosage mg/day third dosage mg/day third patients dosage mg/day patients study patients months treatment Symptom sign scores evaluation scores baseline improvement study period months patients substantial control symptoms Specimens nasal biopsies beginning end treatment decrease eosinophils cellular infiltrates slight tendency increase mast cell counts trend normalization nasal mucosa adverse effects Mean plasma cortisol levels normal corticotropin stimulation baseline months FCB therapy 